FLT3 and acute myeloid leukemia: These methodologies, endorsed by studies such as those of Fernandes and Islam et al. [14,17], have provided invaluable insights into the molecular interactions and binding affinities of potential FLT3 inhibitors, emphasizing the significance of these approaches in AML drug discovery and development.